Mark Identification
RENEGADE THERAPEUTICS CORP.
Serial Number
97688772
Filing Date
Nov 22, 2022
Trademark by
Classification Information
Pharmaceutical preparations for use in the treatment of autoimmune diseases, multiple sclerosis, Crohn's disease, ulcerative colitis, inflammatory disorders, neurological disorders, neurodegenerative disorders, and Epstein-Barr virus associated lymphoproliferative disorders
Pharmaceuticals